High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children. [electronic resource]
Producer: 20191218Description: 102-109 p. digitalISSN:- 1944-7884
- Anti-HIV Agents -- therapeutic use
- Antigens, CD -- blood
- Antigens, Differentiation, Myelomonocytic -- blood
- Biomarkers -- blood
- Child
- Child, Preschool
- Female
- HIV Infections -- complications
- Humans
- Infant
- Male
- Neurodevelopmental Disorders -- etiology
- Neuropsychological Tests
- Predictive Value of Tests
- Proportional Hazards Models
- Receptors, Cell Surface -- blood
- CD163 Antigen
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.